Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-060416
Filing Date
2025-04-30
Accepted
2025-04-29 17:49:44
Documents
15
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A igms-20241231.htm   iXBRL 10-K/A 2130039
2 EX-31.1 igms-ex31_1.htm EX-31.1 9819
3 EX-31.2 igms-ex31_2.htm EX-31.2 10840
  Complete submission text file 0000950170-25-060416.txt   4387388

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20241231.xsd EX-101.SCH 1366828
17 EXTRACTED XBRL INSTANCE DOCUMENT igms-20241231_htm.xml XML 32707
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39045 | Film No.: 25889750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)